Phase II and III Trials: Comparison of Four Chemotherapy Regimens in Advanced Non–Small-Cell Lung Cancer (ECOG 1594)
- 1 August 2000
- journal article
- Published by Elsevier in Clinical Lung Cancer
- Vol. 2 (1) , 21-22
- https://doi.org/10.1016/s1525-7304(11)70620-9
Abstract
No abstract availableKeywords
This publication has 3 references indexed in Scilit:
- Tirapazamine Plus Cisplatin Versus Cisplatin in Advanced Non–Small-Cell Lung Cancer: A Report of the International CATAPULT I Study GroupJournal of Clinical Oncology, 2000
- Comparison of Survival and Quality of Life in Advanced Non–Small-Cell Lung Cancer Patients Treated With Two Dose Levels of Paclitaxel Combined With Cisplatin Versus Etoposide With Cisplatin: Results of an Eastern Cooperative Oncology Group TrialJournal of Clinical Oncology, 2000
- Phase III Trial of Gemcitabine Plus Cisplatin Versus Cisplatin Alone in Patients With Locally Advanced or Metastatic Non–Small-Cell Lung CancerJournal of Clinical Oncology, 2000